# clm_8B2C132F4605

subject: Amgen (/record/amgen.md)  
predicate: total_equity  
value: 24,984,000,000 United States dollar  
valid_from: 2011-03-31  
valid_to: 2011-06-30  
published: 2011-05-10  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_67DA709539BB  
last_updated: 2026-11-08  
cite: AsOf. "Amgen total equity: 24,984,000,000 United States dollar", as of 2011-03-31 (until 2011-06-30). Claim clm_8B2C132F4605, https://asof.is/claim/clm_8B2C132F4605, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/318154/000095012311048073/0000950123-11-048073-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q1 FY2011, filed 2011-05-10  

## Sources

- https://www.sec.gov/Archives/edgar/data/318154/000095012311048073/0000950123-11-048073-index.htm (primary, SEC EDGAR 10-Q Q1 FY2011, published 2011-05-10)

## Supersedes

- [Amgen](/record/amgen.md) | total_equity | 23,944,000,000 United States dollar | valid 2010-12-31 to 2011-03-31 | conf 0.95 | superseded | superseded_by [clm_8B2C132F4605](/claim/clm_8B2C132F4605.md) | [clm_ED303315F19F](/claim/clm_ED303315F19F.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.